Getting the study drug at the right time is challenging for any clinical trial, and this is more prominent with the multi-regional clinical trials. To have the IMPs and ancillaries at the clinical trial sites in time, the sponsors need to have the right people, processes, facilities, and technology in place. Generally, the sites require […]

Read More →